Turbo-Power

Laser atherectomy catheter

Otsige saranaseid tooteid

The Turbo-Power laser atherectomy catheter debulks the lesion in a single step and offers remote automatic rotation for precise directional control. Turbo-Power is the only atherectomy device proven and approved for the treat of ISR.

Omadused
Maximal luminal gain
Maximal luminal gain

Maximal luminal gain

The rotation of the eccentric fiber pack mitigates dead space between the fibers and is more effective on a greater surface area.⁸
Clinical superiority
Clinical superiority

Clinical superiority

The only atherectomy device with level 1 clinical data. The Excite** ISR prospective randomized controlled trial, including challenging real-world cases with the longest lesions ever studied, proves superiority over PTA alone.¹
Precise directional control
Precise directional control

Precise directional control

Remote automatic rotation offers precise directional control allowing the physician to direct treatment into bulk where needed.
Fiber pack eccentric rotation
Fiber pack eccentric rotation

Fiber pack eccentric rotation

Increases crossing efficiency in calcified lesions allowing for better deliverability in difficult cases.¹⁰
  • 1. Dippel et al. Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-stent Restenosis: Initial EXCITE ISR Results (2015). JACC 8(1): 92-101.
  • 2. Saxon et al (2013). Heparin bonded, expanded polytetrafluoroethylene lined stent graft in the treatment of femoropopliteal artery disease. JVIR; 24(2).
  • 3. McKinsey J, Zellar T, Rocha-Singh K, et al. Lower Extremity Revascularization Using Directional Atherectomy: 12-Moth Prospective Results of the DEFINITIVE LE Study, JACC Cardiovasc Interv 7 (2014) pp. 923-933.
  • 4. Maehara A, et al. JETSTREAM Atherectomy System can remove superficial calcium in severely calcified peripheral arteries. Abstract Poster, ISET Jan 2013.
  • 5. Babaev A, et al. Tissue Removal Assessment with Ultrasound of the SFA and Popliteal Study (TRUTH): Orbital Atherectomy Acute Date and Intravascular Ultrasound Analysis. JACC Vol 64/11/Suppl B, TCT-131.
  • 6. Maximal luminal gain defined as 50% or greater stenosis reduction.
  • 7. Spectranetics Benchmark Study, unpublished data available upon request. Coll Cardio. 2004;43:1959-1963.
  • 8. Data on file D040242-00
  • 9. Data on file ECO031891
  • *When comparing 7F Turbo-Power to 2.0 Turbo-Elite. Greater than 10% luminal gain when comparing 6F Turbo- Power to 2.0 Turbo-Elite.
  • **Excite ISR studied the safety and efficacy of Turbo-Tandem plus PTA and PTA alone. Turbo-Power is substantially equivalent to Turbo-Tandem.